ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

EVG Evgen Pharma Plc

0.80
0.00 (0.00%)
24 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Evgen Pharma Plc LSE:EVG London Ordinary Share GB00BSVYN304 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.80 0.75 0.85 0.80 0.80 0.80 227,410 07:46:26
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 422k -4.04M -0.0147 -0.54 2.2M
Evgen Pharma Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker EVG. The last closing price for Evgen Pharma was 0.80p. Over the last year, Evgen Pharma shares have traded in a share price range of 0.75p to 4.05p.

Evgen Pharma currently has 274,888,117 shares in issue. The market capitalisation of Evgen Pharma is £2.20 million. Evgen Pharma has a price to earnings ratio (PE ratio) of -0.54.

Evgen Pharma Share Discussion Threads

Showing 326 to 349 of 13025 messages
Chat Pages: Latest  17  16  15  14  13  12  11  10  9  8  7  6  Older
DateSubjectAuthorDiscuss
30/4/2018
16:30
So nicola, no institutions buying but clearly they have been... News
shirley83
30/4/2018
16:00
Berney I have a sizeable position and no point us arguingHowever to be amicable you have to log onto Twitter and read topinfo and admit he's been mentioning evg!!Eat humble pie!!
nico115
30/4/2018
15:49
Totally agree chesty So many Rampers Could've bought at 13p last week so why pay 18p this week with no news?Been no institutional buying as no volume apart from last Friday 15p target short term
nico115
30/4/2018
15:47
Ouch don't like to say told ya so! But yep told ya so, pump n dump and doubters you don't have to say yep sorry you was right chesty I know!!
chesty1
30/4/2018
14:01
My initial thoughts about EVG, as compared to IMM, are that I am much happier with the science because of the wealth of research papers and the simplicity of the structure and mode of action of the active agent. Also because the chairman, unlike the IMM chairman, is a scientist.

Lots of research, including a very careful assessment of the likely IMM dropout rate via the RNS's, led me to emerge from IMM with sizeable profits intact.

metis20
30/4/2018
13:57
Shirley83 30 Apr '18 - 11:33 - 230 of 246

30p Coming

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

LOL. Blatant ramping surely, Shirley! You need to take lessons in the art of ramping, Shirley. That was a pathetic attempt.

papillon
30/4/2018
13:34
shirley83 more like 8p here
petebarnes1
30/4/2018
13:31
Techs all pointing nicely upwards. News due. Institutions buying more. CEO pitching to big pharma.

If all that isn't a buy signal then I don't know what is.

bernymadoff
30/4/2018
13:17
Done it comes Shirley
chesty1
30/4/2018
13:09
Like IMM and Pli?I'm waiting to buy more Want 15pDoesn't seem to be able to hold a rally Topinfo back ramping evg again today
nico115
30/4/2018
13:06
I'll be happy with incremental daily increases here. Of course there will be those trading the volatility for a few percent but the waiting is where the big money is to be made in stocks like this one
bernymadoff
30/4/2018
12:59
Well, I made a small purchase just in case. However, look at the hype with IMM phase 2 but look what happened. Still nursing my loss.
minky
30/4/2018
12:45
Cliff hanger.........
datait
30/4/2018
12:13
This will continue rising into tbe interim Phase 2 breast cancer results due this quarter.

No point selling down here imho because it is massively undervalued and is nigh on impossible to buy back in any meaningful quantities.

The Phase 2 interim results are due this quarter. In fact the last update referred to them in what I consider to be quite a bullish way.

"The presentation will also refer to the ongoing Phase II trial of SFX-01 in metastatic breast cancer, which is on track to report an interim read-out in Q2 this year with the final read-out around the year end."

The presentation was made last week to the Orphan Drug Conference in the US in the "pitch and partner" section which gives companies an opportunity to showcase their drugs to big pharma.

Now would our CEO be pitching SFX-01 for breast cancer to potential partners if he thought that the interim results were going to be negative.

Add to tbis the fact that institutional holders have increased their positions by 6m shares in the last 3 months and you get an idea of where the share price could be headed in the run up to results.

bernymadoff
30/4/2018
12:07
And the same old a holes... Hoffy, chesty etc.. Always late
shirley83
30/4/2018
12:05
The same namesBabblerShirley Same old same pump and dump merchants
jimmyhoffa262
30/4/2018
12:03
It's in the big boys hands chesty.. You need to be able to see it
shirley83
30/4/2018
11:59
Nit seeing many sellers chesty
babbler
30/4/2018
11:58
Watch the sellers smash it now p&d for sure Shirley and you know it!
chesty1
30/4/2018
11:40
You miss out again chesty.. Always late
shirley83
30/4/2018
11:38
Anyone for a pump n dump oh sorry your all here already?!
chesty1
30/4/2018
11:37
Tried topping up this morning and all 3 brokers only accepting negotiated deals only. Sure sign this is only moving up! 30p plus this week.
joemillion
30/4/2018
11:33
30p Coming
shirley83
30/4/2018
09:16
Cant buy jack online this morning and lots of buying presumably NT. So much for your 15p numb nuts
bernymadoff
Chat Pages: Latest  17  16  15  14  13  12  11  10  9  8  7  6  Older

Your Recent History

Delayed Upgrade Clock